Document Detail


Disease management: remote monitoring in heart failure patients with implantable defibrillators, resynchronization devices, and haemodynamic monitors.
MedLine Citation:
PMID:  23737229     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Heart failure represents a major public health concern, associated with high rates of morbidity and mortality. A particular focus of contemporary heart failure management is reduction of hospital admission and readmission rates. While optimal medical therapy favourably impacts the natural history of the disease, devices such as cardiac resynchronization therapy devices and implantable cardioverter defibrillators have added incremental value in improving heart failure outcomes. These devices also enable remote patient monitoring via device-based diagnostics. Device-based measurement of physiological parameters, such as intrathoracic impedance and heart rate variability, provide a means to assess risk of worsening heart failure and the possibility of future hospitalization. Beyond this capability, implantable haemodynamic monitors have the potential to direct day-to-day management of heart failure patients to significantly reduce hospitalization rates. The use of a pulmonary artery pressure measurement system has been shown to significantly reduce the risk of heart failure hospitalization in a large randomized controlled study, the CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Heart Failure Patients (CHAMPION) trial. Observations from a pilot study also support the potential use of a left atrial pressure monitoring system and physician-directed patient self-management paradigm; these observations are under further investigation in the ongoing LAPTOP-HF trial. All these devices depend upon high-intensity remote monitoring for successful detection of parameter deviations and for directing and following therapy.
Authors:
William T Abraham
Related Documents :
23597479 - Randomised assessment of treatment using panel assay of cardiac markers--contemporary b...
24529949 - Beyond auscultation: acoustic cardiography in clinical practice.
24183909 - Should surgical ablation for atrial fibrillation be performed in patients with a signif...
24217039 - Left atrial appendage closure in patients with atrial fibrillation in whom warfarin is ...
23398819 - Barth syndrome.
23653269 - Relationship between impaired cardiac sympathetic activity and spatial dyssynchrony in ...
21214589 - Female gender is associated with a better outcome after cardiac resynchronization therapy.
14713729 - Stem cells for the heart, are we there yet?
17689679 - Real-time monitoring of cardiac metabolism using biosensors shows myocardial protection...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology     Volume:  15 Suppl 1     ISSN:  1532-2092     ISO Abbreviation:  Europace     Publication Date:  2013 Jun 
Date Detail:
Created Date:  2013-06-05     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100883649     Medline TA:  Europace     Country:  England    
Other Details:
Languages:  eng     Pagination:  i40-i46     Citation Subset:  IM    
Affiliation:
Division of Cardiovascular Medicine, The Ohio State University, 473 West 12th Avenue, Room 110P, Columbus, OH 43210-1252, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Disease management: atrial fibrillation and home monitoring.
Next Document:  Workflow, time and patient satisfaction from the perspectives of Home Monitoring.